These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 16272749

  • 1. Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine.
    Jin M, Shimada T, Shintani M, Yokogawa K, Nomura M, Miyamoto K.
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):324-30. PubMed ID: 16272749
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B.
    Ishizaki J, Ito S, Jin M, Shimada T, Ishigaki T, Harasawa Y, Yokogawa K, Takami A, Nakao S, Miyamoto K.
    Biopharm Drug Dispos; 2008 May; 29(4):195-203. PubMed ID: 18240156
    [Abstract] [Full Text] [Related]

  • 3. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
    Jin M, Shimada T, Yokogawa K, Nomura M, Kato Y, Tsuji A, Miyamoto K.
    Int J Pharm; 2006 Feb 17; 309(1-2):81-6. PubMed ID: 16384676
    [Abstract] [Full Text] [Related]

  • 4. Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone.
    Yokogawa K, Shimada T, Higashi Y, Itoh Y, Masue T, Ishizaki J, Asahi M, Miyamoto K.
    Biochem Pharmacol; 2002 Feb 15; 63(4):777-83. PubMed ID: 11992648
    [Abstract] [Full Text] [Related]

  • 5. Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice.
    Jin M, Shimada T, Yokogawa K, Nomura M, Ishizaki J, Piao Y, Kato Y, Tsuji A, Miyamoto K.
    Biochem Pharmacol; 2006 Oct 16; 72(8):1042-50. PubMed ID: 16939683
    [Abstract] [Full Text] [Related]

  • 6. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation.
    Fricker G, Drewe J, Huwyler J, Gutmann H, Beglinger C.
    Br J Pharmacol; 1996 Aug 16; 118(7):1841-7. PubMed ID: 8842452
    [Abstract] [Full Text] [Related]

  • 7. An antioxidant Trolox restores decreased oral absorption of cyclosporine A after liver ischemia-reperfusion through distinct mechanisms between CYP3A and P-glycoprotein in the small intestine.
    Ikemura K, Inoue K, Mizutani H, Oka H, Iwamoto T, Okuda M.
    Eur J Pharmacol; 2012 Sep 05; 690(1-3):192-201. PubMed ID: 22749977
    [Abstract] [Full Text] [Related]

  • 8. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats.
    Tian X, Chang Y, Wei J, Liu R, Wang L, Zhang J, Zhang X.
    J Pharm Pharmacol; 2019 May 05; 71(5):788-796. PubMed ID: 30663770
    [Abstract] [Full Text] [Related]

  • 9. Influence of cytarabine and cyclophosphamide on the disposition kinetics of cyclosporin A after bone marrow transplantation.
    Shimada T, Aoki Y, Yokogawa K, Nomura M, Ishizaki J, Nishigami J, Miyamoto K.
    Transpl Int; 2003 Nov 05; 16(11):788-93. PubMed ID: 12844214
    [Abstract] [Full Text] [Related]

  • 10. Capsaicin pretreatment increased the bioavailability of cyclosporin in rats: involvement of P-glycoprotein and CYP 3A inhibition.
    Zhai XJ, Shi F, Chen F, Lu YN.
    Food Chem Toxicol; 2013 Dec 05; 62():323-8. PubMed ID: 24013073
    [Abstract] [Full Text] [Related]

  • 11. Effect of clarithromycin on the bioavailability of cyclosporin in rats.
    Ohba M, Ohnishi N, Komada F, Iwakawa S, Okumura K.
    Biol Pharm Bull; 1996 May 05; 19(5):733-7. PubMed ID: 8741585
    [Abstract] [Full Text] [Related]

  • 12. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
    Konishi H, Sumi M, Shibata N, Takada K, Minouchi T, Yamaji A.
    J Pharm Pharmacol; 2004 Oct 05; 56(10):1259-66. PubMed ID: 15482640
    [Abstract] [Full Text] [Related]

  • 13. Effect of atropine on gastrointestinal motility and the bioavailability of cyclosporine A in rats.
    Quijano RF, Ohnishi N, Umeda K, Komada F, Iwakawa S, Okumura K.
    Drug Metab Dispos; 1993 Oct 05; 21(1):141-3. PubMed ID: 8095208
    [Abstract] [Full Text] [Related]

  • 14. Effect of cyclosporine A on the gastrointestinal absorption of acyclovir in neonatal and adult rats.
    Mizuno N, Takagi C, Yamamoto N, Takahashi K.
    Biol Neonate; 1998 Oct 05; 74(3):243-52. PubMed ID: 9691165
    [Abstract] [Full Text] [Related]

  • 15. Brain cyclosporin A levels are determined by ontogenic regulation of mdr1a expression.
    Goralski KB, Acott PD, Fraser AD, Worth D, Sinal CJ.
    Drug Metab Dispos; 2006 Feb 05; 34(2):288-95. PubMed ID: 16303871
    [Abstract] [Full Text] [Related]

  • 16. Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine.
    Takara K, Ohnishi N, Horibe S, Yokoyama T.
    Drug Metab Dispos; 2003 Oct 05; 31(10):1235-9. PubMed ID: 12975332
    [Abstract] [Full Text] [Related]

  • 17. Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats.
    Liu Y, Luo X, Yang C, Yang T, Zhou J, Shi S.
    Mol Med Rep; 2016 Oct 05; 14(4):3073-85. PubMed ID: 27510982
    [Abstract] [Full Text] [Related]

  • 18. In situ intestinal absorption of cyclosporine A solid dispersion in rats.
    Liu C, Zhu S, Zhou Y, Wei Y, Pei Y.
    Drug Dev Ind Pharm; 2008 Jun 05; 34(6):627-31. PubMed ID: 18568913
    [Abstract] [Full Text] [Related]

  • 19. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier.
    Terao T, Hisanaga E, Sai Y, Tamai I, Tsuji A.
    J Pharm Pharmacol; 1996 Oct 05; 48(10):1083-9. PubMed ID: 8953513
    [Abstract] [Full Text] [Related]

  • 20. Long-term pharmacokinetic efficacy and safety of low-dose ritonavir as a booster and atazanavir pharmaceutical formulation based on solid dispersion system in rats.
    Fukushima K, Haraya K, Terasaka S, Ito Y, Sugioka N, Takada K.
    Biol Pharm Bull; 2008 Jun 05; 31(6):1209-14. PubMed ID: 18520056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.